HomeMarketsSharesShiseido Company, Limited

Trade Shiseido Company, Limited - 4911 CFD

Market is not available at the momentMarket information is presented
as of 2026-10-09T06:05:39+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread6.94
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
¥1,000
Overnight funding adjustment
Charges from full value of position
-0.014441 %
(-¥3)

Trade size with leverage ~ ¥20,000

Money from leverage ~ $¥19,000


-0.01444%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
¥1,000
Overnight funding adjustment
Charges from full value of position
-0.007781 %
(-¥2)

Trade size with leverage ~ ¥20,000

Money from leverage ~ $¥19,000


-0.00778%
Overnight funding adjustment time21:00 (UTC)
CurrencyJPY
Min traded quantity1
Margin5.00%
Stock exchangeJapan
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close3249.54
Open3269.82
1-Year Change29.8%
Day's Range3259.93 - 3309.18

Trade Shiseido Company, Limited - 4911

About Shiseido Company, Limited

Shiseido Co Ltd is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, personal care products, barber and beauty products. The Company operates in seven business segments. Japan segment sells of cosmetics, toiletries, personal care products, beauty food and over-the-counter drugs in Japan. China segment and Asia Pacific segment manufacture and sell cosmetics, toiletries and personal care products respectively in China and Asia-Oceania region excluding Japan and China. Americas and Europe segment manufacture and sell cosmetics and toiletries respectively in the Americas, as well as Europe & the Middle East & Africa. Travel Retail segment sells cosmetics and toiletries in duty free shops around the world except Japan. Professional segment sells barber and beauty products. The Company also conducts the frontier science business of cosmetic raw materials and medical drugs, as well as the food and beverage business and personal care product sales business.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Shiseido Company, Limited revenues increased 12% to Y1.035T. Net income applicable to common stockholders totaled Y42.44B vs. loss of Y11.66B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Loss on COVID 19 decrease of 76% to Y4.51B (expense), NOP Other Expenses decrease of 43% to Y2.7B (expense).

Equity composition

FY'94-'02 WAS, & FY'05-'07 1&3Q WAS & O/S were estimated. FY'08 3Q BWAS & DWAS were estimated and BWAS = O/S. FY'08 1Q WAS=O/S. FY'08 1Q & 3Q DWAS were estimated to reflect reported DEPS. FY'10 3Q and FY'11 Q2 DWAS were estimated.

Latest shares articles

A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
12:41, 7 October 2026
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:18, 7 October 2026
Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:43, 6 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready